DB
AZN icon

Dmitry Balyasny’s AstraZeneca AZN Stock Holding History

Dmitry Balyasny’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-71,600
Closed -$13.2M – 2888
2025
Q4 		$13.2M Buy
71,600
+45,300
+172% +$7.94M 0.02% 903
2025
Q3 		$4.04M Buy
+26,300
New +$3.98M 0.01% 1469
2024
Q4 		– Sell
-9,550
Closed -$1.49M – 2726
2024
Q3 		$1.49M Buy
+9,550
New +$1.54M ﹤0.01% 1798
2021
Q1 		– Sell
-175,000
Closed -$17.5M – 1747
2020
Q4 		$17.5M Buy
+175,000
New +$18.5M 0.1% 291
2020
Q3 		– Sell
-100,000
Closed -$10.6M – 1281
2020
Q2 		$10.6M Buy
+100,000
New +$10.3M 0.09% 324
2018
Q4 		– Sell
-205,000
Closed -$15.8M – 1394
2018
Q3 		$15.8M Sell
205,000
-357,500
-64% -$27M 0.07% 355
2018
Q2 		$39.5M Hold
562,500
– – 0.18% 143
2018
Q1 		$39.3M Buy
+562,500
New +$39M 0.16% 172
2017
Q3 		– Sell
-137,500
Closed -$9.38M – 1871
2017
Q2 		$9.38M Buy
+137,500
New +$8.98M 0.04% 556
2016
Q4 		– Sell
-122,230
Closed -$52K – 1341
2016
Q3 		$52K Sell
122,230
-52,770
-30% -$3.45M ﹤0.01% 945
2016
Q2 		$10.6M Buy
+175,000
New +$10.2M 0.07% 337
2015
Q1 		– Sell
-33,500
Closed -$2.36M – 941
2014
Q4 		$2.36M Buy
33,500
+3,500
+12% +$251K 0.02% 544
2014
Q3 		$2.14M Buy
+30,000
New +$2.2M 0.02% 596

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dmitry Balyasny's AZN Position: Q2 2026 in Review

Dmitry Balyasny sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 148,684 shares — an estimated $29.3M sold.

Dmitry Balyasny first reported a position in AZN in Q3 2013 and held it in 31 quarters. The position peaked at $99.1M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Dmitry Balyasny reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 148,684 AstraZeneca shares in Q2 2026, an estimated $29.3M.
  • Dmitry Balyasny first reported a position in AstraZeneca in Q3 2013 and held it in 31 quarters.
  • Dmitry Balyasny's AstraZeneca position peaked at $99.1M in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.